2seventy bio, Inc. (TSVT)
(Delayed Data from NSDQ)
$4.75 USD
+0.19 (4.17%)
Updated Aug 23, 2024 04:00 PM ET
After-Market: $4.75 0.00 (0.00%) 7:58 PM ET
4-Sell of 5 4
F Value D Growth A Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 11/12/24 |
---|---|
Current Quarter | 0.01 |
EPS Last Quarter | -0.29 |
Last EPS Surprise | 17.14% |
ABR | 2.43 |
Earnings ESP
|
-3,400.00% |
---|---|
Current Year | -1.06 |
Next Year | 0.31 |
EPS (TTM) | -3.21 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 17.32M | 23.30M | 59.57M | 93.02M |
# of Estimates | 2 | 1 | 2 | 2 |
High Estimate | 17.64M | 23.30M | 63.73M | 101.15M |
Low Estimate | 17.00M | 23.30M | 55.40M | 84.90M |
Year ago Sales | 12.03M | 10.68M | 100.39M | 59.57M |
Year over Year Growth Est. | 43.97% | 118.16% | -40.66% | 56.17% |
Earnings Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 0.01 | 0.02 | -1.06 | 0.31 |
# of Estimates | 2 | 2 | 2 | 2 |
Most Recent Consensus | 0.35 | 0.26 | -0.09 | 1.39 |
High Estimate | 0.35 | 0.26 | -0.09 | 1.39 |
Low Estimate | -0.33 | -0.22 | -2.03 | -0.78 |
Year ago EPS | -1.00 | -1.11 | -4.42 | -1.06 |
Year over Year Growth Est. | 101.00% | 101.80% | 76.02% | 128.77% |
Agreement - Estimate Revisions
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 0 | 0 | 0 | 0 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 1 | 1 |
Down Last 60 Days | 0 | 0 | 1 | 1 |
Magnitude - Consensus Estimate Trend
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | 0.01 | 0.02 | -1.06 | 0.31 |
7 Days Ago | 0.01 | 0.02 | -1.06 | 0.31 |
30 Days Ago | 0.35 | 0.26 | -0.93 | 0.76 |
60 Days Ago | -0.02 | -0.01 | -1.34 | 0.19 |
90 Days Ago | -0.02 | -0.01 | -1.34 | 0.19 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.33 | -0.22 | -2.03 | -0.78 |
Zacks Consensus Estimate | 0.01 | 0.02 | -1.06 | 0.31 |
Earnings ESP | -3,400.00% | -1,200.00% | -91.51% | -355.74% |
Surprise - Reported Earnings History
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.29 | -0.81 | -1.11 | -1.00 | NA |
Estimate | -0.35 | -0.72 | -1.22 | -1.31 | NA |
Difference | 0.06 | -0.09 | 0.11 | 0.31 | 0.10 |
Surprise | 17.14% | -12.50% | 9.02% | 23.66% | 9.33% |
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more